Athlete monitoring data may be recorded minute by minute throughout a match or training session, while injury information may only indicate whether the entire session was injury-associated. This creates a modelling problem: assigning the same session-level label to every minute would imply that injury status is known at each exact time, even though within-session injury onset is unknown. Our novelty is a fixed-landmark, one-representation-per-athlete-session formulation that directly addresses this mismatch. Instead of labelling every minute, we construct one representation per athlete-session at each landmark using information observed up to that point. This keeps the target at the session level and avoids unsupported minute-level injury supervision. A landmark is a fixed time point within the same session, such as 10, 20, or 30 minutes. At each landmark, we assess whether the whole session is injury-associated or non-injury-associated and examine how discrimination changes as more within-session information becomes available. Using 2020 SoccerMon data, we analyse 3,743 athlete-sessions from 48 elite women's football athletes, including 22 injury-associated sessions from five athletes. We evaluate pre-session, cumulative, dynamic, and combined representations with athlete-disjoint validation, athlete-cluster bootstrap uncertainty, common-cohort sensitivity analysis, alternative negative-athlete fold allocations, equal-athlete weighting, and Logistic Regression, Random Forest, and XGBoost benchmarks. Primary CUM+DYN Logistic Regression yields ROC-AUC 0.367-0.607 and PR-AUC 0.0080-0.0150 across landmarks, with wide uncertainty. PRE-containing representations show higher point estimates at several landmarks but remain uncertain.
Rafael Muñoz-Terol, Jesús Peral, Sandra Amador +1cs.LG cs.AI
Autism spectrum disorder (ASD) is a developmental disability characterized by challenges in social interaction and communication. As the causes of ASD remain unclear, identifying relevant features and hidden correlations is crucial for early diagnosis. This systematic review evaluates 55 studies from 2017 to 2023 on the application of machine learning (ML) techniques to ASD. The primary objective is to examine recent ML applications in ASD research, identifying trends, techniques, and datasets that enhance diagnosis and treatment. Supervised learning methods dominate, as they align well with ASD diagnostic needs; however, the role of deep learning is expanding with greater data availability. Emerging techniques based on hybrid methods, where unsupervised, deep learning, and fuzzy logic could be included, will be interesting to observe in the future. The review highlights key challenges and opportunities, particularly the need for models that can integrate complex data -such as genetic and clinical information- to improve diagnostic accuracy and treatment outcomes. Additionally, incorporating innovative data sources, like wearable devices and biometric sensors, could enable continuous and non-intrusive monitoring, providing a more holistic understanding of ASD. Findings emphasize that addressing current challenges requires interdisciplinary collaboration and expanded datasets tailored to ASD. Future ML models will benefit from broader multimodal data integration, enabling researchers to more comprehensively address the complexities of ASD.
Multimodal data collected by heterogeneous devices are used for collaborative training, where federated learning (FL) serves as a key paradigm for effective distributed modeling with data privacy preservation. However, local training suffers from the forgetting of previously learned global knowledge under cross-client data heterogeneity, which leads to significant declines in both performance and convergence speed. Most previous studies rely on global alignment strategies to retain global knowledge, which hinder local optimization and lead to inadequate supervision of missing classes. Some studies introduce proxy datasets to supplement supervision for missing classes. However, it remains a challenge to balance class-wise global consistency and local optimization objectives without proxy datasets. In this work, we propose FedADB, a Class Anchor-Driven Dual-Branch FL framework. Specifically, the server generates class anchors optimized in a differentiable input space, which are shared across clients. These class anchors serve as global references that provide supervision for missing classes during local training. A dual-branch collaborative training mechanism is designed for clients. In this mechanism, the anchor-based global branch focuses on learning with global consistency, achieving global knowledge alignment by class-anchor balanced sampling. The local calibration branch focuses on learning discriminative local features, mitigating the degradation of local representations caused by excessive global alignment. Extensive experiments across multiple medical and natural datasets demonstrate that FedADB achieves significant improvements in both accuracy and convergence speed.
Julia Gehrmann, Lars Quakulinski, Hamza Naseem +1cs.LG
Access to holistic, multimodal data improves the performance of Artificial Intelligence (AI) in medical classification tasks compared to utilizing single modalities or data sources. However, the inherent heterogeneity and complexity of clinical real-world data pose significant challenges to structured data analysis and AI application. This heterogeneity includes missing values, multiple time points, diverse modalities, and inconsistent formats and semantics. Data harmonization prior to data integration tackles this challenge but remains resource-intensive and error-prone, limiting the scalability and reproducibility of holistic, AI-driven decision support on clinical real-world data. We therefore propose PatTree, a graph-based, holistic representation of patients that can be derived from real-world clinical data through the automated structuring of multimodal clinical data. PatTree enables early-stage data integration without relying on pre-standardized inputs. While representing heterogeneous clinical data within a unified knowledge graph, PatTree preserves the semantic relationships between data elements across modalities and data sources, facilitating interoperability and machine-interpretable data access. Using a subset of the ADNI-1 cohort (n = 763), we demonstrate that classification of patients is directly feasible on PatTree reaching state-of-the-art classification performance. In the three-class classification task distinguishing Alzheimer's disease, mild cognitive impairment, and cognitively normal individuals, we achieve a balanced accuracy of 98.5% and an F$_1$ score of 0.987 on the held-out test set. Our results show that assumption-free, automated structuring of multimodal medical data can serve as a scalable foundation for clinical AI pipelines bypassing tedious data preparation and standardization.
Ruth Amey, Muhammad Arifur Rahman, Taha Osman +4cs.LG cs.AI
Federated learning has emerged as a potential solution to privacy concerns associated with using sensitive health data for training predictive models, particularly in personalised cancer care. This research investigates whether federated learning can support the development of robust models for predicting tumour progression in breast cancer patients while addressing four critical deployment pillars: transparency, scalability, security, and fairness. This study evaluates a federated learning framework using multimodal data, including clinical information, tumour characteristics, biomarker data, and patient demographics, alongside medical imaging data such as MRI scans, to model changes in tumour characteristics over time. The performance of the federated approach was compared with that of a centralised model trained on aggregated data. The report then further examines strategies to enhance secure model updates, maintain performance across patient subgroups, and support scalability across institutions. The findings assess whether federated learning can achieve predictive performance comparable to centralised learning while preserving data locality. These results contribute to understanding the feasibility of privacy-preserving, multimodal predictive modelling and support future applications such as digital twins to assist clinicians and patients in personalised treatment planning.
Medicine is inherently multimodal, requiring clinicians to synthesize information across diverse data streams. Yet the development of multimodal foundation models is constrained by limited access to large-scale, high-quality clinical data. Although PubMed Central (PMC) offers a complementary source of expert-authored image-text data, existing PMC-derived resources remain limited in fidelity, reproducibility, and clinical validation. We introduce MedPMC, an automated, continuously updatable framework that transforms permissively licensed literature into high-fidelity infrastructure for medical multimodal models. Applied to 6.1 million PMC articles, MedPMC curated 11 million medical image-text pairs. Component evaluations showed strong performance for initial screening (F1 = 93.2), multi-panel figure detection (F1 = 96.5), figure separation (mAP = 89.8), caption separation and alignment (F1 = 81.4; ROUGE-L = 85.3), and medical figure classification (F1 = 96.5). Manual review by five annotators, three with medical training, found 95.3% of MedPMC images medically relevant, versus 19.7% in a prior PMC-derived dataset. Across 26 benchmarks spanning 11 specialties, a MedPMC-trained CLIP-style model improved average zero-shot AUC by 7.1 percentage points over the strongest architecture-matched biomedical CLIP baseline despite using fewer than half as many image-text pairs. As the vision encoder in a multimodal large language model, it improved medical visual question-answering by 1.9 and 16.9 percentage points across two benchmarks. In 10,524 Yale New Haven Health System dermatology photographs, it improved morphology-to-image retrieval Recall@5 by 11.7 percentage points. These findings show that high-fidelity literature curation strengthens medical multimodal foundation models across benchmark and clinical settings. We publicly release the framework, corpus, benchmarks, and pretrained models.
- Objective: Multimodal deep learning models in oncology are currently limited by monolithic designs that rigidly couple data ingestion, clinical routing, and artificial intelligence (AI) inference. To address this inflexibility, we propose the Large Cancer Assistant (LCA), a model-agnostic, post-hoc orchestration framework designed for scalable clinical decision support. - Methods: The LCA is mathematically formalized as a 7-tuple architecture grounded in the principle of Algorithmic Impermeability, ensuring the orchestration logic remains strictly independent of underlying black-box AI models. We introduce the Entry Theory, leveraging Geometric Deep Learning (GDL) to standardize multimodal patient data along distinct structural and medical axes. The system dynamically orchestrates data via a Cancer Switching Module and intentionally isolates the core AI execution from volatile hospital IT infrastructures by outputting a Standardized Intermediate Payload (SIP). - Results: A Proof of Concept (PoC) validated the orchestration logic across four technical scenarios. The framework executed a nominal flow with negligible orchestration overhead. It empirically demonstrated algorithmic impermeability by maintaining an invariant routing projection during AI model swaps, and it validated strict failure-safety by achieving a 100\% recall rate in generating targeted Supplementary Data Requests (SDR) under injected data anomalies. Multi-protocol execution capability was also successfully verified. - Conclusion: By structurally decoupling multimodal ingestion from feature inference, the LCA provides a highly adaptable and modular orchestration foundation. The SIP establishes a clear architectural boundary, natively setting the stage for downstream Electronic Medical Record (EMR) interoperability as an independent future paradigm.
Yuankang Zhao, Youngsoo Baek, Felipe A. Medeiros +2stat.ML cs.LG stat.CO
Scalable Bayesian inference for generalized linear mixed models (GLMMs) provides uncertainty-aware analysis of correlated longitudinal data, but existing scalable approaches largely assume low-dimensional tabular predictors and do not directly accommodate high-dimensional modalities such as images and text. We address this limitation by learning one or more modality-specific neural encoders jointly with a GLMM objective, then performing variance-corrected stochasticgradient MCMC for the GLMM parameters conditional on the learned representation. This conditional-Bayes design combines supervised representation learning with posterior uncertainty quantification for population-level effects, subjectspecific heterogeneity, and modality-level random slopes. The resulting model preserves interpretable fixed and random effects for structured covariates and learned modalities while scaling gracefully to large longitudinal datasets. In simulation studies, our method recovers posterior means and variance estimates from full-data MCMC benchmarks after covariance correction. We further evaluate uncertainty through parameter-level interval coverage in simulations and predictive calibration on held-out data. Applications to glaucoma progression and adolescent mental health demonstrate that the framework allows nuanced assessment of the relative importance of each modality on both individual and population levels without sacrificing predictive performance.
Learning causal models from fragmented biomedical data is challenging because clinical, molecular, and imaging variables are often incomplete or not jointly observed. We propose RetiSEM, a domain-constrained structural equation modelling (SEM) framework for causal graph recovery and mediation analysis under limited multimodal resources. This proposed work organises variables into biologically informed blocks, applies forbidden-edge constraints, and decomposes pathway-level effects into TE, NDE, and NIE components. We evaluate RetiSEM across ten synthetic benchmark scenarios that vary in dimensionality, nonlinearity, causal depth, and pathway structure, together with a fragmented real-world setting that combines NHANES clinical variables with externally derived retinal representations. This approach achieves lower structural error and higher causal accuracy than unconstrained baselines across the synthetic benchmarks. In the real-data analysis, retinal variables behave mainly as downstream biomarker-like indicators, with smaller but detectable indirect effects. These findings support our strategy as an interpretable framework for testing structured causal hypotheses in limited-resource biomedical AI. The code and resources for this work are publicly available at: https://github.com/Inamullah-Colab/ReitSEM.
Social disadvantage is associated with multimorbidity, but the pathways linking social conditions to disease burden remain poorly understood. We developed an AI-driven multimodal mediation framework that integrates socioeconomic, psychosocial, clinical, laboratory, behavioral, and genomic data from the All of Us Research Program. Modality-specific variational autoencoders were used to derive latent representations of each data domain, and mediation analyses were subsequently performed in latent space to evaluate indirect associations between socioeconomic disadvantage, psychosocial factors, and multimorbidity. The final analytic cohort included 20,804 participants with complete multimodal data. Across 800 exposure--mediator--outcome combinations, mediation signals were concentrated within a small number of latent dimensions. The strongest indirect association linked a socioeconomic disadvantage dimension, a psychosocial vulnerability dimension, and a cardiometabolic multimorbidity dimension (NIE = 0.002517). The psychosocial dimension was characterized by poorer mental health, greater loneliness, lower social well-being, and lower health literacy, whereas the outcome dimension was associated with hypertension, diabetes, hyperlipidemia, obesity, chronic kidney disease, and heart disease. Bootstrap analyses supported the stability of the leading pathway. These findings suggest that psychosocial vulnerability was strongly represented in the dominant latent pathway linking socioeconomic disadvantage and cardiometabolic multimorbidity. More broadly, the proposed framework illustrates how AI-based representation learning can be used to investigate complex relationships across high-dimensional multimodal health data.
Nathaniel Jeffries, Miriam Wolff, Sam Royston +5cs.LG q-bio.QM
Glucose forecasting algorithms are an important aspect of glycemic control management in type 1 diabetes. So far, the research community has developed numerous algorithms and models for forecasting. However, it is well-recognized that the lack of standardized model performance evaluation benchmarks makes fair comparison difficult and hinders further innovation, and thus benchmark standardization is in urgent need. Furthermore, many published glucose forecasting algorithms are limited to CGM data alone, ignoring other multimodal signals such as insulin dosing and carbohydrate intake. Here, we introduce MetaboNet-Bench, a benchmark for multimodal glucose forecasting for patients with type 1 diabetes that provides an extensible open-source evaluation framework for comparison of glucose forecasting algorithms that leverage glucose, insulin, and carbohydrate data. We then demonstrate its utility by benchmarking several recently published glucose forecasting models and a custom multimodal time-series model, representing different model architectures. The results show that the benefit of adding data modalities is conditioned on the complexity of the model and that incorporating more clinical metrics helps identify meaningful gaps to fill for future research.